To analyze the impact of personalized management by community family doctors on the quality of life of patients with chronic obstructive pulmonary disease (COPD), to provide a reference for exploring prevention and treatment strategies for COPD.

A total of 109 patients with stable COPD who were admitted to Pingjiang Xincheng Community Health Service Center from October 2018 to April 2019 were selected. They were randomly divided into either an experimental group (55 cases) or a control group (54 cases).The control group was given routine drug maintenance therapy, while the experimental group was given individualized management by community family doctors on the basis of routine drug therapy. Comprehensive assessment test (CAT) score, forced expiratory volume in one second/forced vital capacity (FEV₁/FVC), estimated FEV₁ were compared between the two groups before and after management. The percentage of patients with acute exacerbation more than once in 1 year was compared after management.

The CAT scores in the experimental group at 3 and 6 months after management (14.14±7.13 and 13.25±6.24) were significantly lower than that before management (17.61±7.21, P＜0.05) and those in the control group after management (17.14±8.41, 17.42±8.02, P＜0.05). The FEV₁/FVC in the experimental group improved from 59.14±7.3 before administration to 65.56±6.1 after administration (P＜0.05), and the estimated FEV₁ also improved from (48.36±5.20)% before management to (63.22±5.90)% after management (P＜0.05). The percentage of patients with acute exacerbation more than once in one year in the experimental group (16.36%) was significantly lower than that in the control group (33.33%, P＜0.05).

The individualized management by community family doctors significantly improve patients' lung function, which can slow the development of chronic obstructive pulmonary disease.